Navigation Links
Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent

Moffitt Research Presented at 9th International Symposium on Myelodysplastic Syndromes

TAMPA, Fla., May 17, 2007 /PRNewswire/ -- New updated results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) were presented today by Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, at the 9th International Symposium on MDS currently taking place in Florence, Italy. Breakthrough data presented at the meeting showed that Revlimid, or lenalidomide, can provide long-term survival benefit and prevent disease progression in MDS patients with chromosome 5q deletion.

"These landmark data demonstrate that Revlimid, in many cases, can help patients with MDS live transfusion free for several years. More importantly, we found that Revlimid can provide a significant long-term survival advantage, with 87 percent of cytogenic responders having a ten-year survival estimate," said Dr. List, Professor of Oncology and Medicine and Chief, Division of Malignant Hematology at Moffitt, and lead investigator of the study. "It is very rewarding to see patients treated with Revlimid, living longer, living three or four years transfusion free and having a better quality of life overall."

The updated data presented by Dr. List at this year's Symposium showed that patients with MDS with chromosome 5q deletion who received Revlimid were able to remain transfusion free for an average of 2.2 years and, after four years, patients were still responding to treatment. Additionally, among patients who showed a cytogenic response to Revlimid, 87 percent had a ten year survival estimate compared to only four percent of non-cytogenic responders.

Additional data from a retrospective analysis of a German database on MDS patients treated with Revlimid was also presented at the Symposium and showed that Revlimid can also prevent dis
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/22/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... executive officer Howie Rosen will be presenting ... Tim Morris will be presenting at JMP ... are as follows: Jefferies 2015 Healthcare Conference ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "North ... & Graft), by Application (Surgical Wound, & Ulcer), ... Forecast to 2019" report to their offering. ... wound care market is estimated to grow at ...
(Date:5/21/2015)...  Cardica, Inc. (Nasdaq: CRDC ) today announced that ... the company,s vice president of operations, was granted an option ... a per share exercise price of $0.43, the closing trading ... pursuant to Cardica, Inc.,s Inducement Plan, which was approved by ... 5653(c)(4) of the Nasdaq Global Market for equity grants to ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
(Date:5/22/2015)... Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they are ... cosmetic, restorative and other dental treatments. At consultations, ... interest them. Questions regarding what certain treatments can ... also be covered during this initial appointment. If ...
(Date:5/22/2015)... Alexandria, VA (PRWEB) May 22, 2015 ... be presented at the American Society of Clinical ... May, demonstrated improved survival rates for those patients ... standard chemotherapy regimen of pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, ... vessel growth), and it is already routinely used ...
(Date:5/22/2015)... In an effort to support the athletes of ... donate $5 dollars for every maintenance call, and $25 ... system. Customers have their needs serviced, and donations contributed ... the Special Olympics receives money. Hence the name Everybody ... million athletes, and boasts a myriad of events. This ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A new ... featuring experts in the field of Physical Therapy. ... that takes the mystery out of physical therapy and ... range of motion for a variety of ailments and ... establish a personalized exercise plan that enhances daily activities ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of ... on religious leaders to make changes in order to achieve ... blog, discusses the history of war, how it started, why ... says mankind was created to lead peaceful, joyful lives, very ... , “Yahweh created mankind, according to His Plan, which is ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2
... "What in the world is raw milk?" Or perhaps you,ve debated ... turkey drumstick - or safe for you to eat food from ... To address these and other hot topics surrounding food safety, the ... "Chew on This," dedicated to examining issues related to food safety ...
... Part D is under way and seniors are facing ... down their choices for the coming year. Medicare enrollees ... for any changes in cost or coverage and make ... Walgreens pharmacists will be one of the best resources ...
... group, specialists in the field of advanced and flexible ... development agreement with In-Q-Tel, the independent strategic investment firm ... of the broader U.S. Intelligence Community. , ... the development of febit,s Geniom(R) Technology to detect pathogens ...
... Nov. 19 The American Heartworm Society,strongly urges ... their pets. It,s important not to cut ... cause harm to pets, and could actually,increase the ... The,warning comes as this year,s increase in ...
... - The American College of Physicians (ACP) and the ... joint statement on the importance of adult vaccination against ... been endorsed by 17 other medical societies representing a ... for Disease Control and Prevention, 95 percent of vaccine-preventable ...
... 19 At a time when tens of thousands of Americans ... and Washington state received top scores in a new ... Arkansas , North Dakota and South Dakota ... Scorecard on State Roadway Laws: A Blueprint for Injury Prevention , ...
Cached Medicine News:Health News:AVMA Launches 'Chew on This' Podcast Series on Food Safety 2Health News: Walgreens Offers Help Sorting Through Changes to Medicare Part D Plans : Free personalized report available at every Walgreens makes it easier for seniors to identify their best choices for prescription coverage 2Health News: Walgreens Offers Help Sorting Through Changes to Medicare Part D Plans : Free personalized report available at every Walgreens makes it easier for seniors to identify their best choices for prescription coverage 3Health News:febit Announces Strategic Investment and Technology Development Agreement With In-Q-Tel 2Health News:febit Announces Strategic Investment and Technology Development Agreement With In-Q-Tel 3Health News:Heartworm Disease Prevention Protects Pets, Wallets 2Health News:Medical societies: Adults need vaccines 2Health News:Oregon, Washington State Doing the Most to Promote Roadway Safety, According to New Emergency Nurses Association National Scorecard 2Health News:Oregon, Washington State Doing the Most to Promote Roadway Safety, According to New Emergency Nurses Association National Scorecard 3
1000L...
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Inquire...
Medicine Products: